What is agilon health Inc (AGL) stock price today?

agilon health Inc (AGL) currently trades at $27.89 per share. The stock has a market capitalization of $464.64M and a P/E ratio of —x.

Is AGL stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, agilon health Inc has a Smart Value Score of 41/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is 1.82.

What is agilon health Inc's revenue and earnings?

agilon health Inc has trailing twelve-month (TTM) revenue of $5.93B with profit margins of -6.60%. Earnings per share (EPS) is $-24.50.

Is agilon health Inc financially healthy?

agilon health Inc's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of 1.82 places it in the grey zone.

AGL

agilon health Inc

NYSE: AGL · HEALTHCARE · MEDICAL CARE FACILITIES

$27.89

-0.04% today

Updated 2026-04-29

Market cap

$464.64M

P/E ratio

—

P/S ratio

0.08x

EPS (TTM)

$-24.50

Dividend yield

—

52W range

$7 – $120

Volume

3.3M

Market cap

$464.64M

P/E ratio

—

P/S ratio

0.08x

EPS (TTM)

$-24.50

Dividend yield

—

52W range

$7 – $120

Volume

3.3M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

8.0

Growth

5.5

Quality

C+

2.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

1.8

Altman Z-Score

Grey zone

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$20.71

-25.74%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy13 Hold0 Sell2 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.12x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at -6.60%

- Negative free cash flow $-37.57M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$2.39B	$4.32B	$6.06B	$5.93B	$5.93B
Net income	$-106.55M	$-262.60M	$-260.15M	$-405.35M	$-188.88M
EPS	—	—	—	—	$-24.50
Free cash flow	$-163.47M	$-187.01M	$-71.03M	$-119.00M	$-37.57M
Profit margin	-4.46%	-6.08%	-4.29%	-6.83%	-6.60%

Recent insider activity

Date	Insider	Type	Shares	Price
2026-04-01	ZAMORE, DENISE	Buy	50,000	—
2026-04-01	ZAMORE, DENISE	Sale	1,024	$9.75
2026-04-01	VENKATACHALIAH, GIRISH	Buy	28,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
AGL	$464.64M	41	8.0	2.0	5.0	5.5	—	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

agilon health Inc trades at $27.89. Our Smart Value Score of 41/100 indicates the stock is fair. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 1.82, it sits in the grey zone. TTM revenue stands at $5.93B. with profit margins at -6.60%.

Frequently asked questions

What is agilon health Inc's stock price?

agilon health Inc (AGL) trades at $27.89.

Is agilon health Inc overvalued?

Smart Value Score 41/100 (Grade D, Sell).

What is the price target of agilon health Inc (AGL)?

The analyst target price is $20.71, representing -25.7% downside from the current price of $27.89.

What is agilon health Inc's revenue?

TTM revenue is $5.93B.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

1.82 — grey zone.

Company info

SectorHEALTHCARE

IndustryMEDICAL CARE FACILITIES

CountryUSA

ExchangeNYSE

CurrencyUSD

www.agilonhealth.com

Quick metrics

P/S ratio0.08x

ROE-135.60%

Beta0.33

50D MA$16.76

200D MA$22.88

Shares out0.02B

Float0.01B

Short ratio—

Avg volume3.3M

Performance

1 week-1.48%

1 month+8580.77%

3 months+3297.88%

YTD+3951.11%

1 year—

3 years—

5 years—

Compare

AGL vs LLY →AGL vs JNJ →AGL vs ABBV →Stock screener →